- Home
- VATE vs BRNS Comparison
VATE vs BRNS Comparison
Compare VATE & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VATE
- BRNS
- Stock Information
- Founded
- VATE 1994
- BRNS 2016
- Country
- VATE United States
- BRNS United Kingdom
- Employees
- VATE N/A
- BRNS N/A
- Industry
- VATE Metal Fabrications
- BRNS Biotechnology: Pharmaceutical Preparations
- Sector
- VATE Industrials
- BRNS Health Care
- Exchange
- VATE Nasdaq
- BRNS Nasdaq
- Market Cap
- VATE 49.2M
- BRNS 52.0M
- IPO Year
- VATE 1996
- BRNS 2021
- Fundamental
- Price
- VATE $3.92
- BRNS $1.19
- Analyst Decision
- VATE
- BRNS Strong Buy
- Analyst Count
- VATE 0
- BRNS 2
- Target Price
- VATE N/A
- BRNS $4.00
- AVG Volume (30 Days)
- VATE 90.8K
- BRNS 39.3K
- Earning Date
- VATE 11-07-2024
- BRNS 11-07-2024
- Dividend Yield
- VATE N/A
- BRNS N/A
- EPS Growth
- VATE N/A
- BRNS N/A
- EPS
- VATE N/A
- BRNS N/A
- Revenue
- VATE $1,364,600,000.00
- BRNS N/A
- Revenue This Year
- VATE N/A
- BRNS $27.18
- Revenue Next Year
- VATE N/A
- BRNS N/A
- P/E Ratio
- VATE N/A
- BRNS N/A
- Revenue Growth
- VATE N/A
- BRNS N/A
- 52 Week Low
- VATE $3.25
- BRNS $1.11
- 52 Week High
- VATE $15.60
- BRNS $5.10
- Technical
- Relative Strength Index (RSI)
- VATE 50.40
- BRNS 42.84
- Support Level
- VATE $3.25
- BRNS $1.15
- Resistance Level
- VATE $4.16
- BRNS $1.35
- Average True Range (ATR)
- VATE 0.23
- BRNS 0.07
- MACD
- VATE 0.05
- BRNS 0.01
- Stochastic Oscillator
- VATE 73.08
- BRNS 20.00
About VATE INNOVATE Corp.
Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments which are; The infrastructure segment is comprised of DBM Global Inc, a fully integrated industrial construction, structural steel, and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services, The Life Sciences segment is comprised of Pansend Life Sciences which seeks to develop products to treat early osteoarthritis of the knee and aesthetic and medical technologies for the skin, and Spectrum segment is comprised of HC2 Broadcasting Holdings Inc which operates over-the-air broadcasting stations across the United States.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic that guide the immune system to overcome chronic infectious diseases, autoimmunity and cancer.